Abstract In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-
2), a novel variant of coronavirus has emerged from Wuhan in China and has created havoc …

Por meio da sua facilidade de transmissão e altas taxas de mortalidade, o SARS-CoV-2 até
2021 já infectou mais de 15 milhões de brasileiros. Além do período de incubação e …

Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) is responsible for recent
ongoing public health emergency in the world. Sharing structural and behavioral similarities …

Background COVID-19 is a multisystemic disease characterized by respiratory distress.
Disease severity is associated with several factors. Here we characterize virological findings …

The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …

Coronavirus Disease 2019 (COVID‐19) has become a major health problem causing severe
acute respiratory illness in humans. It has spread rapidly around the globe since its first …

OBJECTIVE: In late December 2019 in Wuhan (China), Health Commission reported a
cluster of pneumonia cases of unknown etiology, subsequently isolated and named Severe …

Since SARS-CoV-2 first appeared in humans, the scientific community has tried to gather as
much information as possible in order to find effective strategies for the containment and …

With the large number of individuals infected and recovered from Covid-19, there is intense
discussion about the quality and duration of the immunity elicited by SARS-CoV-2 infection …

The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …